Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-20-129076
Filing Date
2020-11-24
Accepted
2020-11-24 17:18:25
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-3/A tm2037012d1_s3a.htm S-3/A 465537
2 EXHIBIT 5.1 tm2037012d1_ex5-1.htm EX-5.1 37630
3 EXHIBIT 23.2 tm2037012d1_ex23-2.htm EX-23.2 2436
4 EXHIBIT 23.3 tm2037012d1_ex23-3.htm EX-23.3 2779
5 GRAPHIC tm2035656d1_ex5-1img001.jpg GRAPHIC 9691
6 GRAPHIC tm2035656d1_s3img001.jpg GRAPHIC 35093
7 GRAPHIC tm2035656d1_s3img002.jpg GRAPHIC 18447
8 GRAPHIC tm2035656d1_s3img003.jpg GRAPHIC 40152
  Complete submission text file 0001104659-20-129076.txt   646925
Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-250041 | Film No.: 201345294
SIC: 2834 Pharmaceutical Preparations